Related Experiment Video
Updated: May 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus (HCV) infection in Africa: a review
Mercy Jelagat Karoney1, Abraham Mogisi Siika
1Moi University Clinical Research Center, Eldoret, Kenya.
Insights
Hepatitis C virus (HCV) is a global pandemic, with Africa experiencing the highest prevalence. Limited data on HCV epidemiology and treatment in Africa suggest it remains a neglected disease, necessitating further research.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) is a significant cause of chronic liver disease globally.
- Africa faces a high burden of HCV, yet data on its epidemiology and management are scarce.
Purpose of the Study:
- To review the current epidemiology and management of Hepatitis C in Africa.
- To identify gaps in knowledge regarding HCV prevalence, genotypes, transmission, and treatment in the African continent.
Main Methods:
- Literature search of Medline and bibliographies using keywords: "Hepatitis C", "Prevalence", "Epidemiology", "Africa", "Treatment".
- Inclusion of articles published after 1995.
- Data summarization and presentation in tables and figures.
Main Results:
- Africa has the highest regional HCV prevalence (5.3%), with Egypt showing the highest national prevalence (17.5%).
- Common HCV genotypes in Africa are 1, 4, and 5; genotype 3 is prevalent in Egypt and Central Africa.
- Blood transfusion is a primary transmission route. Data on standard treatments (peginterferon, ribavirin) and liver transplantation in Africa are notably absent.
Conclusions:
- Hepatitis C is a neglected disease in many African countries due to limited available data.
- Urgent need for more research on HCV epidemiology, transmission, and effective management strategies across Africa.
Abstract:
Hepatitis C virus (HCV) is a viral pandemic and a leading cause of chronic liver disease. This review highlights the epidemiology and management of Hepatitis C in Africa. We searched for articles on medline using the terms, "Hepatitis C", "Prevalence", "Epidemiology", "Africa" and "Treatment". The bibliographies of the articles found were used to find other references. We included articles published after 1995 only. The data was summarized and presented in tables and figures. Africa has the highest WHO estimated regional HCV prevalence (5.3%). Egypt has the highest prevalence (17.5%) of HCV in the world. Genotypes commonly found in Africa are 1, 4 and 5. Genotype 3 is found in Egypt and parts of Central Africa. Blood transfusion is a major means of acquisition of HCV infection. While treatment with peginterferon and ribavirin is recommended for patients with chronic HCV, no data were found on their use in Africa. Neither were there any data on definitive management (liver transplantation) for those with end stage disease. Data on HCV infection in Africa are scarce. This suggests that hepatitis C is still a neglected disease in many countries. Limited data exist in literature on HCV in Africa.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Cytomegalovirus Disease
Cirrhosis I: Introduction
Sexually Transmitted Infections

